PDL Biopharma
PDLI
#8394
Rank
A$0.42 B
Marketcap
A$3.73
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -A$0.2 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are A$80.61 Million. In 2019 the company made an earning of -A$94.18 Million a decrease over its 2018 earnings that were of -A$66.13 Million.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-A$0.2 Billion110.54%
2019-A$94.18 Million42.43%
2018-A$66.13 Million-121.38%
2017A$0.30 B60.41%
2016A$0.19 B-77.09%
2015A$0.84 B3.09%
2014A$0.81 B26.65%
2013A$0.64 B19.82%
2012A$0.53 B3.68%
2011A$0.51 B77.17%
2010A$0.29 B-35.29%
2009A$0.45 B23.45%
2008A$0.36 B-1751.42%
2007-A$22.21 Million-88.56%
2006-A$0.2 Billion93.73%
2005-A$0.11 Billion13.63%
2004-A$88.15 Million32.12%
2003-A$66.72 Million87.44%
2002-A$35.6 Million-302.45%
2001A$17.58 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$52.52 B-26,529.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.69 B-8,501.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.17 Billion-16.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A$52.7 M-126.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-A$0.24 Billion 16.39%๐Ÿ‡บ๐Ÿ‡ธ USA